Search results for Camrelizumab
Camrelizumab, Abbexa, abx831403
Camrelizumab is a monoclonal antibody biosimilar expressed in CHO cells, targeting PDCD1/PD-1/CD279, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications. Camrelizumab is under investigation in clinical trial NCT03417895 (SHR-1210 Combined With Apatinib in Treatment of ED-SCLC After Failure of First Line Standard Therapy).
Host
Human
Reactivity
Human
Applications
ELISA, WB
Conjugation
Unconjugated
Camrelizumab Biosimilar - Research Grade, ichor.bio, ICH5003
Detects human PD-1. This non-therapeutic antibody uses the same sequence as the therapeutic antibody Camrelizumab.
Host
Humanized
Reactivity
Human
Applications
Conjugation
Research Grade Camrelizumab (HS870116), abinScience, HS870116
Host
Humanized
Reactivity
Human
Applications
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Conjugation
Please provide the required information below so that we can quickly source your products.